Clinical trial
Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate…
NCT00421694 · University of L'Aquila, Other · Completed
Key facts
| NCT number | NCT00421694 |
|---|---|
| Title | Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide |
| Lead sponsor | University of L'Aquila, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Bicalutamide |
| Enrollment | 119 |
| First posted | Jan 12, 2007 |
| Last update posted | Oct 8, 2007 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: